Alpha Pharma Rexogin Lab Test Results

Summary

Alpha Pharma Healthcare Rexogin is presented in a box of ten 1-milliliter ampules, each labeled to contain 50 milligrams of stanozolol (Winstrol) per milliliter. As part of its harm reduction initiative, AnabolicLab procured samples of this product from a European-based internet source between May 15, 2017, and June 23, 2017, to assess the product’s label claims and quality.

The samples were submitted to SIMEC AG, an independent and accredited analytical laboratory, for a detailed analysis, including HPLC-UV quantitative dosage testing, as well as microbiological contamination testing. AnabolicLab fully funded this analysis to ensure transparency and provide unbiased information. The findings revealed a significant discrepancy between the claimed and actual dosage, highlighting the importance of independent testing in protecting consumers. These results are published exclusively for educational and harm reduction purposes.

Testing Results and Authentication

The samples were received by SIMEC AG on June 23, 2017, and the report was finalized on August 11, 2017.

The product was identified with the following details:

Batch Number: RX1505
Serial Number: HHUV17A4GY
Authentication Code: 78495fnuH (successfully verified on check-alpha.com)
Manufacturing Date: October 2015
Expiration Date: March 2019

Product Overview

Manufacturer: Alpha Pharma Healthcare
Product Name: Rexogin
Active Ingredient: Stanozolol (Winstrol)
Batch Number: RX1505
Serial Number: HHUV17A4GY
Authentication Code: 78495fnuH
Manufacturing Date: October 2015
Expiration Date: March 2019
Delivery Method: Injectable (1-milliliter ampules; 10 ampules per box)
Specification: 50 mg/ml stanozolol

Sample Acquisition and Testing

Date Purchased: Between May 15, 2017, and June 23, 2017
Source: European-based internet supplier
Product Submitted By: AnabolicLab
Analysis Paid For By: AnabolicLab
Analysis Performed By: SIMEC AG
Date Received by Lab: June 23, 2017
Date Report Completed: August 11, 2017

Testing Results

Quantitative Dosage Testing (HPLC-UV):

Claimed Dosage: 50 mg/ml stanozolol
Measured Dosage: 41.1 mg/ml stanozolol
Accuracy: 82.2% (below label claim)
Variance: -17.8% (measured dosage was 17.8% below the label claim)

Microbiological Contamination Testing:

Total Aerobial Microbiological Count (TAMC): No contamination detected
Total Yeast and Mold Count (TYMC): No contamination detected

Conclusion

The analysis of Alpha Pharma Healthcare Rexogin revealed a significant underdosage, with a measured concentration of 41.1 mg/ml stanozolol, representing 82.2% accuracy compared to the label claim of 50 mg/ml. While the product was authenticated using its serial number and verification code, the underdosed results raise concerns about the product’s consistency and manufacturing quality. No microbiological contamination was detected, confirming the product’s sterility.

By providing these results, AnabolicLab emphasizes the importance of independent testing in fostering accountability and helping consumers make informed decisions.

Commitment to Harm Reduction

AnabolicLab is committed to reducing harm by independently analyzing anabolic steroid products and publishing accurate lab results. This approach provides transparency, ensures product reliability, and supports consumer safety in an often unregulated market.

Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the Alpha Pharma Rexogin lab test results on the AnabolicLab Forum.